- アズワンのAXELショップ
- 試薬
- 特定メーカー試薬
- US Biological(antibodypab)
-
84-2140-01 Delta Opioid Receptor (OPRD1, D-OR-1, Delta-Type Opioid Receptor, Delta Opioid Receptor, Delta Opiate Receptor, Delta Opioid Receptor 1, Delta-1 Opioid Receptor, Opioid delta Receptor, DOR-1, Opioid Receptor, delta 1, OPRD) 50ug 170376
84-2140-01 Delta Opioid Receptor (OPRD1, D-OR-1, Delta-Type Opioid Receptor, Delta Opioid Receptor, Delta Opiate Receptor, Delta Opioid Receptor 1, Delta-1 Opioid Receptor, Opioid delta Receptor, DOR-1, Opioid Receptor, delta 1, OPRD) 50ug 170376
特徴
- OPRD1 is an Opioid Receptor that is involved in the control of anxiety, depression, and pain.
- It is a promising target in the therapy of mood-altering disorders and drug addiction.
- Delta and kappa opioid receptors function synergistically by forming heterodimers.
- Applications:Suitable for use in Immunohistochemistry.
- Other applications not tested.
- Recommended Dilution:Immunohistochemistry (Formalin fixed paraffin embedded): 32ug/mlOptimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:50ug
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, 0.09% sodium azide.
- Specificity:Recognizes human Delta Opioid Receptor. Species Crossreactivity: gorilla and monkey.
- Isotype:IgG
- Calc Applications Abbrev:IHC
- Calc Crossreactivity:Hu Mk
- Immunogen:Synthetic peptide corresponding to 16aa from the C-terminus of human Delta Opioid Receptor.
- Shelf Life:1year
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]